Covered recipient · General Payments record
ASHLEY MAY HILBRAND
Allopathic & Osteopathic Physicians Family Medicine
General Payments · PY2019–2024
$380.55
- Reported across 20 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $227.15 | 12 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Amgen Inc. | $42.66 | 2 |
| Novo Nordisk AS | $39.66 | 2 |
| Acerta Pharma LLC | $30.37 | 2 |
| Exact Sciences Corporation | $24.98 | 1 |
| Alkermes, Inc. | $21.75 | 1 |
| Lundbeck LLC | $21.02 | 1 |
| Lilly USA, LLC | $16.88 | 1 |
| E.R. Squibb & Sons, L.L.C. | $16.70 | 1 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $13.13 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (12)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Alkermes, Inc. | $21.75 | 03/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1120516198 | CMS |
| Amgen Inc. | $20.92 | 10/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111599162 | CMS |
| Amgen Inc. | $21.74 | 12/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111599164 | CMS |
| AstraZeneca Pharmaceuticals LP | $13.18 | 10/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105262946 | CMS |
| AstraZeneca Pharmaceuticals LP | $17.19 | 11/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104633693 | CMS |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $13.13 | 11/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1118145154 | CMS |
| E.R. Squibb & Sons, L.L.C. | $16.70 | 11/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1101339621 | CMS |
| Exact Sciences Corporation | $24.98 | 12/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114531237 | CMS |
| Lilly USA, LLC | $16.88 | 04/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136051761 | CMS |
| Lundbeck LLC | $21.02 | 11/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145925096 | CMS |
| Novo Nordisk Inc | $19.88 | 02/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096588883 | CMS |
| Novo Nordisk Inc | $19.78 | 06/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097663425 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2019, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.